Effect of bombesin on lower esophageal sphincter pressure in humans.
Intravenous infusion of bombesin in humans results in increased serum gastrin levels and increased lower esophageal sphincter pressure. To differentiate a gastrin- from a nongastrin-mediated mechanism, the effect of intravenous bombesin infusion on lower esophageal sphincter pressure was studied in 5 healthy subjects and in 5 antrectomized patients. Lower esophageal sphincter pressure was recorded by three continuously perfused catheters with side-openings located 5 mm apart. Blood samples were taken at regular intervals during the study periods to assay gastrin and pancreatic polypeptide. Manometric tracings and blood samples were coded and evaluated blindly. Lower esophageal sphincter pressure increased during bombesin infusion both in normal and antrectomized subjects. The increase had a delayed onset and persisted after discontinuation of bombesin. No correlation was found between lower esophageal sphincter pressure and serum gastrin or pancreatic polypeptide values. These data indicate that the effect of bombesin on lower esophageal sphincter pressure is not gastrin or pancreatic polypeptide mediated.
D000328:Adult; D001839:Bombesin / Q000494:pharmacology*; D004943:Esophagogastric Junction / Q000187:drug effects*; D005260:Female; D005755:Gastrins / Q000097:blood / Q000502:physiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D010191:Pancreatic Polypeptide / Q000097:blood; D010455:Peptides / Q000494:pharmacology*; D011312:Pressure; D011706:Pyloric Antrum / Q000601:surgery
D005755:Gastrins; D010455:Peptides; D010191:Pancreatic Polypeptide; D001839:Bombesin